Skip to main content
Clinical Trials/NCT04010643
NCT04010643
Unknown
Not Applicable

Clinical and Economic Evaluation of Neurocognitively-Enhanced Online Cognitive Behavioural Therapy to Promote Functional Recovery Among Community-Living Individuals With Depression: OPTM Study (Online Psychological Treatments for Low Mood)

University of Southern Denmark1 site in 1 country134 target enrollmentOctober 24, 2018
ConditionsDepression

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
University of Southern Denmark
Enrollment
134
Locations
1
Primary Endpoint
Depressive symptoms at end of treatment
Last Updated
6 years ago

Overview

Brief Summary

To evaluate the clinical efficacy of online cognitive behavioural therapy supplemented with online neurocognitive remediation therapy to improve mood and cognition, decrease relapse rates and optimise work and occupational functioning.

Detailed Description

Depression is the most prevalent mental disorder with high relapse rates. Direct costs to Europe represent 1% of its total economy. Following usual treatment, mood improves or fully recovers but cognitive deficits often persist, preventing full return to normal social function. These deficits worsen with repeated depressive episodes and are a significant predictor of relapse. Preventing depression relapse remains one of the biggest therapeutic challenges in the field. While effective short-term therapies, such as cognitive behavioural therapy (CBT), exist, all are associated with high relapse rates. Online neurocognitive remediation therapy (oNCRT), by its potential to rehabilitate impaired cognition in depression, offers an innovative solution to this mental health problem. This trial aims to test the effectiveness and cost-effectiveness of neurocognitively enhanced online CBT to improve mood and cognition in depression, optimise everyday functioning and prevent depression relapse over six months follow-up, using a randomised active-control parallel-groups research design. Individuals presenting with at least mild depression (n=134) are randomly assigned to one of two treatment allocations: online CBT (oCBT) or neurocognitively enhanced online CBT (oCBT+oNCRT) for 20 one-hour sessions over 5 weeks (i.e., four weekly sessions). Before randomisation and within a week of the final allocated session, mood, attention, memory and planning abilities will be assessed. All participants will be then followed for six-months to determine if the mood and cognitive benefits of the oCBT+oNCRT are maintained with the passage of time compared to the control group (oCBT alone). Standard measures of daily functioning (e.g., work ability, occupational function) and economic cost-effectiveness data will be obtained at the same time points. Demonstrating the oNCRT effectiveness as an adjunct to CBT will contribute towards optimising connected healthcare solutions for depression.

Registry
clinicaltrials.gov
Start Date
October 24, 2018
End Date
January 31, 2022
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maria Semkovska

Principal Investigator of OPTM Study

University of Southern Denmark

Eligibility Criteria

Inclusion Criteria

  • scoring a minimum of 14 on the BDI-II,
  • internet access
  • computer access
  • English-speaking fluency

Exclusion Criteria

  • scoring less than 14 on BDI

Outcomes

Primary Outcomes

Depressive symptoms at end of treatment

Time Frame: through study completion, an average of 1 year

The Beck's Inventory for Depression - II (BDI-II; Beck et al., 1996) assesses the self-report severity of currently experienced depressive symptoms. The total score of 21 items is used.The scale score ranges 0 to 63, with higher values indicating more severe depression. Scores are to be interpreted as follows: 0-8: no depression; 9-13: subsyndromal depressive symptoms; 14-19: mild depression; 20-28: moderate depression; 29-63: severe depression.

Relapse rates at 6 months follow-up

Time Frame: through study completion, an average of 1 year

Percent individuals, whose Beck's Inventory for Depression - II score at end of treatment was below 14, but returned to above 14 at 6-months follow-up

Secondary Outcomes

  • Verbal working memory (cognitive outcome 5)(through study completion, an average of 1 year)
  • Planning ability (cognitive outcome 6)(through study completion, an average of 1 year)
  • Work and Social Adjustment (occupational outcome 1)(through study completion, an average of 1 year)
  • Inhibition ability (cognitive outcome 3)(through study completion, an average of 1 year)
  • Immediate verbal memory (cognitive outcome 1)(through study completion, an average of 1 year)
  • Flexibility ability (cognitive outcome 4)(through study completion, an average of 1 year)
  • Costs Associated with Mental Healthcare (economic main assessment)(through study completion, an average of 1 year)
  • Delayed verbal memory (cognitive outcome 2)(through study completion, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials